Seeing Is Believing
Currently out of the existing stock ratings of Jason Wittes, 65 are a BUY (83.33%), 13 are a HOLD (16.67%).
Analyst Jason Wittes works with a stock forecast success ratio of 45.89% fulfilled within 113.11 days on average. Previously, Jason Wittes worked at NORTHLAND CAPITAL MARKETS, AEGIS, BREAN.
Jason Wittes’s has documented 148 price targets and ratings displayed on 18 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on OFIX, Orthofix Medical at 07-Mar-2024.
Analyst best performing recommendations are on LMAT (LEMAITRE VASCULAR).
The best stock recommendation documented was for LMAT (LEMAITRE VASCULAR) at 7/29/2015. The price target of $13 was fulfilled within 2 days with a profit of $1.18 (9.98%) receiving and performance score of 49.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
9
$6.6 (275.00%)
2 months 5 days ago
0/3 (0%)
$6.25 (227.27%)
Buy
7
$4.6 (191.67%)
9.5
1 years 9 months 25 days ago
0/2 (0%)
$4.94 (239.81%)
Buy
10
$7.6 (316.67%)
10
2 years 5 months 23 days ago
0/5 (0%)
$5.7 (132.56%)
Which stock is Jason Wittes is most bullish on?
Which stock is Jason Wittes is most reserved on?
What Year was the first public recommendation made by Jason Wittes?